Serafol AB0+D Bedside Test Streptococci Serafol AB0+D bedside test

Serafol AB0+D bedside test

the test is functioning properly

150 mm long

urine from 32 patients with biopsy-confirmed bladder cancer and 112 healthy individuals without bladder tumours was tested with the NADAL® Nuclear Matrix Protein 22 Test

Serafol AB0+D Bedside Test Streptococci Serafol AB0+D bedside testProduct overview Blood group test AB0+D Coloured test reagents Simple test procedure Reliable results within 2 minutes 1 pack contains 50 test kits The Serafol AB0+D bedside test from sifin is used to quickly determine blood type at the patient's bed, greatly increasing the safety of the blood transfusion. The coloured test reagents reduce the risk of an incorrect reading, while the labelling fields on the bedside test guarantee the correct allocation